Establishing (177)Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate Cancer

Clinical (177)Lu-PSMA-617 radioligand therapy (RLT) is applied in advanced-stage prostate cancer. However, to the best of our knowledge murine models to study the biologic effects of various activity levels have not been established. The aim of this study was to optimize specific and total activity...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Nucl Med
मुख्य लेखकों: Fendler, Wolfgang P., Stuparu, Andreea D., Evans-Axelsson, Susan, Lückerath, Katharina, Wei, Liu, Kim, Woosuk, Poddar, Soumya, Said, Jonathan, Radu, Caius G., Eiber, Matthias, Czernin, Johannes, Slavik, Roger, Herrmann, Ken
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Society of Nuclear Medicine 2017
विषय:
Theranostics
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944167/
https://ncbi.nlm.nih.gov/pubmed/28546332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.193359
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन